Mitsuyo Itabashi

1.6k total citations
76 papers, 1.2k citations indexed

About

Mitsuyo Itabashi is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Mitsuyo Itabashi has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Nephrology, 25 papers in Pulmonary and Respiratory Medicine and 14 papers in Rheumatology. Recurrent topics in Mitsuyo Itabashi's work include Renal Diseases and Glomerulopathies (41 papers), Vasculitis and related conditions (23 papers) and Chronic Kidney Disease and Diabetes (11 papers). Mitsuyo Itabashi is often cited by papers focused on Renal Diseases and Glomerulopathies (41 papers), Vasculitis and related conditions (23 papers) and Chronic Kidney Disease and Diabetes (11 papers). Mitsuyo Itabashi collaborates with scholars based in Japan and Pakistan. Mitsuyo Itabashi's co-authors include Kosaku Nitta, Takashi Takei, Takahito Moriyama, Keiko Uchida, Yuki Tsuruta, Ken Tsuchiya, Ayami Ochi, Chihiro Iwasaki, Ari Shimizu and Misao Tsukada and has published in prestigious journals such as PLoS ONE, Medicine and Journal of Clinical Pathology.

In The Last Decade

Mitsuyo Itabashi

70 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mitsuyo Itabashi

Since Specialization

Citations

This map shows the geographic impact of Mitsuyo Itabashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyo Itabashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyo Itabashi more than expected).

Fields of papers citing papers by Mitsuyo Itabashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyo Itabashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyo Itabashi. The network helps show where Mitsuyo Itabashi may publish in the future.

Co-authorship network of co-authors of Mitsuyo Itabashi

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyo Itabashi. A scholar is included among the top collaborators of Mitsuyo Itabashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyo Itabashi. Mitsuyo Itabashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Successful treatment with bortezomib for refractory cryoglobulinemic vasculitis triggered by ischemic non-obstructive coronary artery disease 2025 ·CEN Case Reports ·(unknown), (unknown), (unknown), (unknown), Yoshitaka Kondo, (unknown), (unknown), (unknown), Noriyuki Suzuki, (unknown), Hirofumi Rokutan, Wako Yumura, Tomio Arai, Akihito Ishigami, Mitsuyo Itabashi, Takashi Takei	0
2	Usefulness of assessment of the Clinical Frailty Scale and the Dementia Assessment Sheet for Community-based Integrated Care System 21-items at the time of initiation of maintenance hemodialysis in older patients with chronic kidney disease 2024 ·PLoS ONE ·(unknown), Mitsuyo Itabashi, (unknown), (unknown), (unknown), (unknown), (unknown), Masahiro Arai, (unknown), Takako Saitô, (unknown), Noriyuki Suzuki, Yuki Tsuruta, Takashi Takei	1
3	Anti-glomerular basement membrane disease developing 3 years after the development of Sweet syndrome and 1 year after the development of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report 2022 ·CEN Case Reports ·(unknown), Mitsuyo Itabashi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wako Yumura, Tomio Arai, Takashi Takei	1
4	Citrullinated histone H3 expression in anti‐neutrophil cytoplasmic antibody‐associated vasculitis in older Japanese autopsy patients 2019 ·Geriatrics and gerontology international ·Yoko Matsuda, Mitsuyo Itabashi, (unknown), Takahiko Sugihara, (unknown), Tomoyasu Matsubara, Shigeo Murayama, Wako Yumura, Akira Shimizu, Takashi Takei, Tomio Arai	2
5	Long-term outcomes of initial therapy for idiopathic membranous nephropathy 2016 ·Clinical and Experimental Nephrology ·Masayo Sato, Takashi Takei, Takahito Moriyama, Mitsuyo Itabashi, Kosaku Nitta	5
6	Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 2016 ·Clinical and Experimental Nephrology ·Yoshihiro Arimura, Eri Muso, Shoichi Fujimoto, Midori Hasegawa, Shinya Kaname, Joichi Usui, (unknown), Masaki Kobayashi, Mitsuyo Itabashi, Kiyoki Kitagawa, Junichi Hirahashi, Kenjiro Kimura, Seiichi Matsuo	38
7	Antineutrophil cytoplasmic antibody-associated glomerulonephritis with immunoglobulin deposition 2016 ·Clinical and Experimental Nephrology ·(unknown), Mitsuyo Itabashi, Takashi Takei, Kazuho Honda, Kosaku Nitta	12
8	Characteristics of IgA nephropathy in advanced-age patients 2014 ·International Urology and Nephrology ·(unknown), Takahito Moriyama, Mitsuyo Itabashi, Takashi Takei, Kosaku Nitta	14
9	Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease 2014 ·Clinical Rheumatology ·Yuki Tsuruta, Toshio Mochizuki, Takahito Moriyama, Mitsuyo Itabashi, Takashi Takei, Ken Tsuchiya, Kosaku Nitta	48
10	Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment 2014 ·Medicine ·(unknown), Takashi Takei, Takahito Moriyama, Mitsuyo Itabashi, Kosaku Nitta	33
11	Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis 2014 ·Modern Rheumatology ·(unknown), Mitsuyo Itabashi, Takashi Takei, Kosaku Nitta	10
12	High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a 2014 ·Journal of Nephrology ·Takahito Moriyama, Mitsuyo Itabashi, Takashi Takei, Hiroshi Kataoka, Masayo Sato, Ari Shimizu, (unknown), (unknown), Keiko Uchida, Kosaku Nitta	30
13	A novel autoantibody against moesin in the serum of patients with MPO-ANCA-associated vasculitis 2013 ·Nephrology Dialysis Transplantation ·Koya Suzuki, Tomokazu Nagao, Mitsuyo Itabashi, Yoshitomo Hamano, Ryuichi Sugamata, Yuji Yamazaki, Wako Yumura, Sachiko Tsukita, Pichao Wang, Toshinori Nakayama, Kazuo Suzuki	36
14	Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis 2012 ·Clinical and Experimental Nephrology ·Takashi Takei, Mitsuyo Itabashi, Takahito Moriyama, Ari Shimizu, Yuki Tsuruta, Ayami Ochi, (unknown), Chihiro Iwasaki, Keiko Uchida, Kosaku Nitta	2
15	Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts 2012 ·Clinical and Experimental Nephrology ·Eri Muso, Tomomi Endo, Mitsuyo Itabashi, (unknown), (unknown), (unknown), Toshiyuki Komiya, (unknown), Wako Yumura, Takao Sugiyama, Kensuke Joh, Kazuo Suzuki	41
16	Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease 2011 ·International Urology and Nephrology ·Takahito Moriyama, Yuki Tsuruta, Chiari Kojima, Mitsuyo Itabashi, Hidekazu Sugiura, Takashi Takei, Tetsuya Ogawa, Keiko Uchida, Ken Tsuchiya, Kosaku Nitta	17
17	Comparison of Steroids and Angiotensin Receptor Blockers for Patients with Advanced IgA Nephropathy and Impaired Renal Function 2011 ·American Journal of Nephrology ·Takahito Moriyama, (unknown), Ayami Ochi, Yuki Tsuruta, Ari Shimizu, Mitsuyo Itabashi, Takashi Takei, Keiko Uchida, Kosaku Nitta	12
18	Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome 2011 ·Clinical and Experimental Nephrology ·(unknown), Takashi Takei, Chiari Kojima, (unknown), Mitsuyo Itabashi, Kosaku Nitta	10
19	A case study of initiating hemodialysis in a patient with tetralogy of Fallot (TOF) 2009 ·Nihon Toseki Igakkai Zasshi ·Ari Shimizu, Takashi Takei, Takahito Moriyama, Mitsuyo Itabashi, Shigeru Otsubo, Takashi Akiba, Kosaku Nitta	3
20	Two cases of ANCA‐associated vasculitis in post‐transplant kidney: relapse and de novo 2009 ·Clinical Transplantation ·(unknown), Kazuho Honda, Takahito Moriyama, Mitsuyo Itabashi, Sekiko Taneda, Takashi Takei, Kazunari Tanabe, Satoshi Teraoka, Yutaka Yamaguchi, Hideaki Oda, Kosaku Nitta	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact